DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

PTC Therapeutics, Inc. (NASDAQ: PTCT)

51.21 0.47 (0.93%)

Quote as of

company name or ticker

Recent Quotes

PTCT $51.21 0.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.85
Previous Close $50.74
Daily Range $49.89 - $52.20
52-Week Range $26.02 - $78.72
Market Cap $1.7B
P/E Ratio -14.33
Dividend (Yield) $0.00 (0.0%)
Volume 548,850
Average Daily Volume 617,460
Current FY EPS -$4.76



PTC Therapeutics, Inc. (PTCT) Description

PTC Therapeutics, Inc. Website:

News & Commentary

3 Soaring Clinical-Stage Biotechs, and 1 to Buy

One Motley Fool digs into three top performing biotech stocks and discovers one that may still be worth buying.

PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q2 2015 Results - Earnings Call Transcript

Today's Dead Cat Bounce Stock: PTC Therapeutics (PTCT)

Tuesday's ETF Movers: GDXJ, XBI

PTC Therapeutics (PTCT) Jumps: Stock Surges 14.4% - Tale of the Tape

PTC Therapeutics (PTCT) Jumps: Stock Surges 14.4% - Tale of the Tape

Health Care Sector Update for 07/15/2015: PTCT,BGMD,RDHL

Why Shares in PTC Therapeutics, Inc. Are Soaring 10% Higher Today

Investor optimism for PTC Therapeutics is climbing ahead of confirmatory phase 3 results that could advance a U.S. filing for approval.

Strong On High Relative Volume: PTC Therapeutics (PTCT)

The Race To Cure Duchenne Muscular Dystrophy - An Investor's Guide

Insider Trading Alert - PTCT, HES And HTGC Traded By Insiders

See More PTCT News...